GETINGE AB-UNSPONSORED ADR Business Summary

Getinge AB (GNGBY) is a global medical technology leader that generates revenue through a B2B model encompassing the sale of advanced medical hardware, high-margin consumables, and recurring service maintenance contracts. The company’s operations are organized into three core segments: Acute Care Therapies, which provides life-support systems for intensive care and cardiovascular procedures; Surgical Workflows, offering integrated operating room equipment and sterile supply management; and Life Science, focusing on contamination prevention and bioprocessing for the pharmaceutical sector. Getinge holds a world-leading position in the extracorporeal membrane oxygenation (ECMO) and infection control markets. It competes primarily with Baxter International, Terumo Corporation, and Steris, distinguishing itself through a premium, high-tech portfolio that integrates clinical hardware with digital health infrastructure. Founded in 1904 by Olander Larsson, Getinge is led by President and CEO Mattias Perjos, who has steered the company since 2017 following senior leadership roles at Coesia and Flexlink. The executive leadership includes CFO Agneta Palmér, appointed in 2024, who brings deep financial expertise from the AB Volvo Group and her previous tenure as Getinge’s Vice President of Corporate Control. Strategic continuity is maintained by Chairman Johan Malmquist, a former CEO of the group, and Vice Chairman Carl Bennet, whose investment firm, Carl Bennet AB, remains the controlling shareholder with over 50% of voting rights as of July 2026. The company’s governance is further supported by significant institutional holdings from AMF Pension and the Fourth Swedish National Pension Fund.